(Q35563056)

8 August 2017

Development of standardized laboratory methods and quality processes for a phase III study of the RTS, S/AS01 candidate malaria vaccine (English)

1 reference

8 August 2017

0 references

1 reference

7

Brian Greenwood

1 reference

8 August 2017

5

Chris Drakeley

1 reference

8 August 2017

17

Bernhards Ogutu

1 reference

8 August 2017

Peter Gottfried Kremsner

6

object named as

Peter Kremsner

1 reference

8 August 2017

8

Opokua Ofori-Anyinam

1 reference

8 August 2017

10

Tonya Villafana

1 reference

8 August 2017

2

Johan Vekemans

1 reference

8 August 2017

12

Barbara Savarese

1 reference

ORCID Public Data File 2021

8 August 2017

1 reference

author name string

Christine Swysen

1

1 reference

8 August 2017

Myriam Bruls

3

1 reference

8 August 2017

Sunny Oyakhirome

4

1 reference

8 August 2017

Brenda Okech

9

1 reference

8 August 2017

Terrell Carter

11

1 reference

8 August 2017

Adriano Duse

13

1 reference

8 August 2017

Andrea Reijman

14

1 reference

8 August 2017

Charlotte Ingram

15

1 reference

8 August 2017

John Frean

16

1 reference

8 August 2017

Clinical Trials Partnership Committee

18

1 reference

8 August 2017

4 August 2011

1 reference

8 August 2017

1 reference

8 August 2017

10

1 reference

8 August 2017

223

1 reference

Creative Commons Attribution 2.0 Generic

8 August 2017

start time

4 August 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

exact match

https://scigraph.springernature.com/pub.10.1186/1475-2875-10-223

0 references

cites work

Assessment of severe malaria in a multicenter, phase III, RTS, S/AS01 malaria candidate vaccine trial: case definition, standardization of data collection and patient care

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220650

Safety and efficacy of the RTS, S/AS01 E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220650

Evaluation of the safety and immunogenicity of the RTS,S/AS01 E malaria candidate vaccine when integrated in the expanded program of immunization

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220650

Long-term safety and efficacy of the RTS,S/AS02A malaria vaccine in Mozambican children

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220650

Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220650

Safety and immunogenicity of RTS,S/AS02D malaria vaccine in infants

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220650

Building clinical trials capacity for tuberculosis drugs in high-burden countries

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220650

Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220650

Sharing benefits in international health research. Research-capacity building as an example of an indirect collective benefit

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220650

Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220650

Moral standards for research in developing countries: from "reasonable availability" to "fair benefits".

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220650

Comparison of two simple methods for determining malaria parasite density

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220650

Measurement of malaria vaccine efficacy in phase III trials: report of a WHO consultation

12 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1475-2875-10-223

Comparison of methods for the rapid laboratory assessment of children with malaria

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220650

Ethics. Fair benefits for research in developing countries

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220650

15 November 2018

Identifiers

DOI

10.1186/1475-2875-10-223

1 reference

Dimensions Publication ID

8 August 2017

0 references

1 reference

8 August 2017

1 reference